|
Gallstones are present in about 80% of people with gallbladder cancer.
This cancer is very rare, however, even among people with gallstones.
Certain conditions in the gallbladder pose a higher than average risk for
cancer:
Porcelain Gallbladders. People with gallstones and so-called
porcelain gallbladders have a very high risk for cancer. (In this
condition, the gallbladder walls have become so calcified that they look
like porcelain on an x-ray.) Whether gallstones themselves cause the
cancer or whether some factor in bile is responsible for both conditions
is unknown. One study demonstrated that gallbladder removal reduced the
likelihood of bile duct cancer, suggesting that gallstones themselves were
responsible.
Gallbladder Polyps and Primary Scerlosing Cholangitis. Polyps
(growths) are sometimes detected during diagnostic tests for gallbladder
disease. Small gallbladder polyps (up to 10 mm) pose little or no risk,
but large ones (greater than 15 mm) pose some risk for cancer, so the
gallbladder should be removed. Patients with polyps 10 mm to 15 mm have a
lower risk but they should still discuss removal of their gallbladder with
their physician. Of special note is a condition called primary sclerosing
cholangitis, which causes inflammation and scarring in the bile duct. It
is associated with a lifetime risk of 7% to 12% for gallbladder cancer.
The cause is unknown, although primary sclerosing cholangitis tends to
strike younger men who have ulcerative colitis. Polyps are often detected
in this condition and have a very high likelihood of malignancy.
Symptoms of gallbladder cancer are usually not present until the disease
has reached an advanced stage and may include weight loss, anemia,
recurrent vomiting, and a lump in the abdomen. When the cancer is caught
at an early stage and has not spread deeper than the mucosa (the inner
lining), removal of the gallbladder results in five-year survival rates of
68%. If cancer has spread to deeper layers, more extensive surgery or
other treatments may be required.
WHO GETS GALLSTONES AND GALLBLADDER DISEASE?
About 20 million Americans harbor gallstones. Only 1% to 3% of the
population, however, complains of symptoms during the course of a year,
and less than have of these people will experience recurrent symptoms.
Risk Factors in Women
Women are much more likely than men to develop gallstones. They occur in
nearly 25% of women in the US by age 60 and up to 50% by age 75. (Again,
in most cases they are asymptomatic.) In general, women are probably at
increased risk because estrogen stimulates the liver to remove more
cholesterol from blood and divert it into the bile.
Pregnancy. Pregnancy increases the risk for gallstones, although
they may disappear after delivery. Pregnant women with stones are more
likely to have symptoms than nonpregnant women.
Hormone Replacement Therapy. Several large studies have shown that
use of hormone replacement therapy results in a twofold to threefold
increased risk for gallstones or gallbladder surgery. Estrogen has an
effect on the liver itself and raises triglycerides, a fatty acid that
increases the risk for cholesterol stones. Recent studies on HRT reporting
negative effects on the heart and increased risks for breast cancer are
also making this treatment a less attractive option for most
postmenopausal women. [ See , Menopause, Estrogen Loss, and Their
Treatments.] )
Risk Factors in Men
About 20% of men have gallstones by the time they reach 75 years of age.
Because most cases are asymptomatic, however, the rates may be
underestimated in older men. One study of nursing home residents reported
that 66% of the women and 51% of the men had gallstones. Men who have
their gallbladders removed, moreover, are more likely to have severe
disease and operative complications than women.
Risks in Children
Gallstone disease is relatively rare in children. When gallstones occur in
this age group they are more likely to be pigment stones. Girls do not
seem to be at a higher risk than boys. The following conditions may put
children at higher risk:
Ethnicity
Because gallstones is
related to diet, particularly fat intake, the incidence of gallstones
varies widely among nations and regions. For example, Hispanics and
Northern Europeans have a higher risk for gallstones than people of Asian
and African descent do. (People of Asian descent who develop gallstones
are most likely to have the brown pigment type.)
Native North and South Americans, such as Pima Indians in the US and
native populations in Chile and Peru, are especially prone to developing
gallstones. Pima women have an 80% chance of developing gallstones during
their lives, and virtually all Native American women in Chile and Peru
develop gallstones during their lifetimes. Such cases are most likely due
to a combination of genetic and dietary factors.
Genetics
Having a family member or close relative with gallstones may increase the
risk of gallstones. Up to a third of cases of painful gallstones may be
related to genetic factors, although the genetics of gallbladder disease
remains poorly understood. Many genes may be involved, including those
that lead to obesity or other risk factors that predispose to gallstones.
Diabetes
People with diabetes are at higher risk for gallstones and have a higher
than average risk for acalculous gallbladder disease (without stones).
Gallbladder disease may progress more rapidly in patients with diabetes,
who tend to develop worse infections in general.
Obesity and Weight Changes
Obesity. Being overweight is a significant risk factor for
gallstones. In such cases, the liver overproduces cholesterol and delivers
it into the bile, which then becomes supersaturated. Some evidence
suggests that specific dietary factors (saturated fats and refined sugars)
are the primary culprit in these cases, although studies are conflicting.
Animal studies, however, suggest that obesity itself, not any particular
foods, triggers the process leading to cholesterol supersaturation and the
formation of stones.
Weight Cycling. Rapid weight loss or weight cycling (dieting and
then putting back weight) further increases cholesterol production in the
liver, with resulting supersaturation and risk for gallstones. A 2000
study suggested the following rates for gallstones related to extreme and
rapid weight loss:
About one-third of
gallstone cases in these situations are symptomatic. The risk for
gallstones is highest in the following dieters:
-
Those who lose more than
24% of their initial body weight.
-
Those who lose more than
1.5 kg (3.3. lb) per week.
-
Those on very low-fat,
low-calorie diets.
Weight cycling also puts
people at risk for gallstones. For example, a 16-year study found that the
risk for gallstone surgery was 68% higher for women who lost and then
regained more than 20 lb at least once than in women whose weight remained
stable.
Cholesterol and Cholesterol-Lowering Drugs
Gallstone formation does not correlate with overall cholesterol levels,
but persons with low HDL cholesterol (the so-called good cholesterol)
levels or high triglyceride levels are at increased risk for stones. In
fact, the cholesterol-lowering drugs gemfibrozil (Lopid) and clofibrate (Atromid-S)
reduce cholesterol levels in the blood by increasing the amount secreted
into the bile, thus creating a higher risk for gallstones. (Other
cholesterol-lowering agents do not have this effect.) [See Well-Connected
report #23, Cholesterol.]
Other Risk Factors
Prolonged Intravenous Feeding. Prolonged intravenous feeding
reduces the flow of bile and increases the risk for gallstones.
Crohn's Disease. Crohn's disease, an inflammatory bowel disorder,
leads to poor reabsorption of bile salts from the digestive tract and
substantially increases the risk of gallbladder disease. Patients older
than 60 and those who have had numerous bowel surgeries (particularly in
the region where the small and large bowel meet) are at especially high
risk.
Cirrhosis. Cirrhosis poses a major risk for gallstones,
particularly pigment gallstones.
Diuretics. In addition to the cholesterol-lowering drugs mentioned
above, thiazide diuretics may slightly increase the risk for gallstones.
Blood Disorders. Chronic hemolytic anemia, including sickle cell
anemia, increases the risk for pigment gallstones.
HOW CAN GALLSTONES AND GALLBLADDER DISEASE BE PREVENTED?
Dietary Considerations
Dietary Factors. Some studies have suggested that certain
dietary factors may be protective:
-
Although fats have been
associated with gallstone attacks -- particularly saturated fats (found
in meats, butter, and other animal products) -- evidence suggests that
fat intake may have benefits under specific conditions. Some studies,
for example, have found a lower risk for gallstones in people who
consumed foods containing monounsaturated fats (found in olive and
canola oils) or omega-3 fatty acids (found in canola, flaxseed, and,
particularly, fish oil). A 2002 study reported that a fatty meal
improved liver clearance in patients who had undergone endoscopic
sphincterotomy, a procedure for removing common bile duct stones.
-
High intake of fiber has
been associated with a lower risk for gallstones.
-
Low levels of lecithin,
a type of fat known as a phospholipid and a key component of bile, may
precipitate the formation of cholesterol gallstones. Animal studies have
suggested that lecithin-rich soy and buckwheat protein may protect
against gallstones. (Buckwheat may be more protective than soy.) Dietary
lecithin is available in health food stores and is found in eggs,
soybeans, liver, wheat germ, and peanuts. There is no evidence, however,
that lecithin supplements or foods containing it can prevent gallstones
in humans.
-
High intake of sugar has
been associated with an increased risk for gallstones.
-
Alcohol in small amounts
(one ounce per day) has been found to reduce the risk of gallstones in
women by 20%. It should be stressed that alcohol is easily abused, and
higher amounts may increase the risk of many diseases, including breast
cancer, in women.
-
Ascorbic acid (vitamin
C) appears to help break cholesterol down in bile. Vitamin C
deficiencies have been associated with a higher risk for gallstones. One
2000 study, which confirmed some previous research, reported that
supplements were associated with a reduced risk for gallbladder disease
in women. (Vitamin C had no effect one way or the other in men.)
-
In one study, men who
drank two or more cups of regular coffee daily (instant, filtered, or
espresso) had a 40% lower risk of developing gallbladder disease over 10
years than men who did not drink coffee regularly. Those who drank more
than four cups had the lowest risk. A more recent study in 2000 did not
find any general protective effect, although women with gallstones who
drank coffee reported fewer symptoms than those who didn't.
Preventing Gallstones
during Weight Loss. Maintaining a normal weight and avoiding rapid
weight loss are the keys to reducing the risk of gallstones. Taking the
medication ursodiol (also called ursodeoxycholic acid, or Actigall) during
weight loss may reduce the risk for people who are very overweight and
need to lose weight quickly. This medication is ordinarily used to
dissolve existing gallstones. It should be noted, however, that it is very
expensive. A promising 2001 study suggested that orlistat (Xenical), a
drug for treating obesity, may protect against gallstone formation during
weight loss. The drug appears to reduce bile acids and other components
involved in gallstone production.
Exercise
Exercising regularly and vigorously may reduce the risk of gallstones and
gallbladder disease, even in people who are overweight. Studies are
reporting a lower risk for gallstones in both men and women who exercise.
Active sports exercise appears to be most protective for both men and
women. A 1999 study of women reported that exercise reduced gallstone risk
regardless of whether the women lost weight or not. Some evidence suggests
that in addition to controlling weight, exercise helps reduce cholesterol
levels in the biliary tract, which could help prevent gallstones.
Nonsteroidal Anti-Inflammatory Drugs
Some data had indicated that taking nonsteroidal anti-inflammatory drugs (NSAIDs)
such as ibuprofen (Advil) protects against the development of gallstones.
Recent studies have been mixed, although a 2001 study reported significant
protection against gallstone recurrence in people who took NSAIDs after
being treated with lithotripsy.
HOW ARE GALLSTONES AND GALLBLADDER DISEASE DIAGNOSED?
The diagnostic challenge posed by gallstones is to be sure that abdominal
pain is caused by stones and not by some other condition. Ultrasound or
other imaging techniques usually detect gallstones readily. Nevertheless,
because gallstones are common and most cause no symptoms, simply finding
stones does not necessarily explain a patient's pain, which may be caused
by numerous other ailments.
Ruling Out Other Disorders
In patients with abdominal pain, causes other than gallstones are usually
responsible if the pain lasts less than 15 minutes, frequently comes and
goes, or is not severe enough to limit activities.
Irritable Bowel Syndrome. Irritable bowel syndrome (IBS) has some
of the same symptoms as gallbladder disease, including difficulty
digesting fatty foods. In IBS, however, pain usually occurs in the lower
abdomen.
Other Conditions with Similar Symptoms. Acute appendicitis,
inflammatory bowel disease (Crohn's disease or ulcerative colitis),
pneumonia, stomach ulcers, gastroesophageal reflux and hiatal hernia,
viral hepatitis, kidney stones, urinary tract infections, diverticulosis
or diverticulitis, pregnancy complications, and even a heart attack may
mimic a gallbladder attack.
Physical Examination
A physical exam often reveals tenderness in the upper right area of the
abdomen in acute cholecystitis and sometimes in biliary colic. There is
usually no tenderness in chronic cholecystitis.
Laboratory Tests
Blood tests are usually normal in people with simple biliary colic or
chronic cholecystitis. The following abnormalities may indicate gallstones
or complications:
-
The enzyme alkaline
phosphatase and bilirubin are usually elevated in acute cholecystitis,
and especially choledocholithiasis (common bile duct stones). Bilirubin
is the orange-yellow pigment found in bile. High levels cause jaundice,
which gives the skin a yellowish tone.
-
Liver enzymes known as
aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are
elevated when common bile duct stones are present. A threefold or more
increase in ALT strongly suggests pancreatitis.
-
A high white blood cell
count is a common finding in many (but not all) patients with
cholecystitis.
Imaging Techniques for
Diagnosing Gallstones and Infection (Cholecystitis)
Ultrasound. Ultrasound, the diagnostic method most frequently used
to detect gallstones, is a simple, rapid, and noninvasive imaging
technique. Ultrasound detects gallstones as small as 2 mm in diameter with
an accuracy of 90% to 95%. Some experts recommend that if an ultrasound
does not detect stones, but gallstones are still strongly suspected, the
test should be repeated.
The patient must not eat for six or more hours before the test, which
takes only about 15 minutes. During the procedure, the physician can check
the liver, bile ducts, and pancreas and quickly scan the gallbladder wall
for thickening (characteristic of cholecystitis). Air in the gallbladder
wall may indicate gangrene.
Ultrasound is not as useful for common bile duct stones and cannot image
the cystic duct. According to one 2000 study, ultrasound is not useful for
identifying cholecystitis in patients who do not have gallstones but have
fever and abdominal pain. In this study, ultrasound detected some
gallbladder abnormalities, no matter what the cause of the abdominal pain.
In only a few cases were the symptoms actually caused by cholecystitis.
Cholescintigraphy. Cholescintigraphy, a nuclear imaging technique,
is not as useful as ultrasound for detecting gallstones, but it is more
sensitive for diagnosing acute cholecystitis. It is noninvasive but can
take one to two hours or longer. The procedure involves the following
steps:
-
A tiny amount of a
radioactive dye is injected intravenously. This material is excreted
into bile.
-
A camera detects the dye
as it passes from the liver into the gallbladder.
-
If the dye does not
enter the gallbladder, the cystic duct is obstructed, thereby indicating
acute cholecystitis.
The scan cannot identify
individual gallstones. Nor can it detect chronic cholecystitis.
Occasionally the scan gives false positive results. (In other words, it
appears to detect acute cholecystitis in people who do not have the
condition.) Such results are most likely in alcoholic patients with liver
disease or patients who are fasting or receiving all nutrients
intravenously.
Oral Cholecystography. Oral cholecystography uses a tablet
containing a dye that is employed during an x-ray. It has been available
since 1924 but is not performed very often anymore. It may be useful in
some cases for determining the structural and functional status of the
gallbladder, often before non-surgical procedures. |